AstraZeneca and Karolinska Institutet PET Centre Announce Molecular Imaging Research Agreement

AstraZeneca and Karolinska Institutet today announced a three year collaborative research agreement that will apply state-of-the-art molecular imaging technologies to generate novel diagnostic imaging tools and further the development of AstraZeneca’s neuroscience research and development pipeline.

Read the full press release